Literature DB >> 28437537

Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States.

Stacey A Fedewa1, Elizabeth M Ward1, Otis Brawley2, Ahmedin Jemal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28437537      PMCID： PMC5818810          DOI： 10.1001/jamainternmed.2017.0340

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  5 in total

Review 1.  Accuracy of self-reported cancer-screening histories: a meta-analysis.

Authors:  Garth H Rauscher; Timothy P Johnson; Young Ik Cho; Jennifer A Walk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04-01       Impact factor: 4.254

2.  Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.

Authors:  Jim C Hu; Paul Nguyen; Jialin Mao; Joshua Halpern; Jonathan Shoag; Jason D Wright; Art Sedrakyan
Journal:  JAMA Oncol       Date:  2017-05-01       Impact factor: 31.777

3.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

Review 4.  American Cancer Society guideline for the early detection of prostate cancer: update 2010.

Authors:  Andrew M D Wolf; Richard C Wender; Ruth B Etzioni; Ian M Thompson; Anthony V D'Amico; Robert J Volk; Durado D Brooks; Chiranjeev Dash; Idris Guessous; Kimberly Andrews; Carol DeSantis; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2010-03-03       Impact factor: 508.702

5.  Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.

Authors:  Ahmedin Jemal; Stacey A Fedewa; Jiemin Ma; Rebecca Siegel; Chun Chieh Lin; Otis Brawley; Elizabeth M Ward
Journal:  JAMA       Date:  2015-11-17       Impact factor: 56.272
  5 in total
  12 in total

1.  Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.

Authors:  Stacey A Fedewa; Ted Gansler; Robert Smith; Ann Goding Sauer; Richard Wender; Otis W Brawley; Ahmedin Jemal
Journal:  Ann Fam Med       Date:  2018-03       Impact factor: 5.166

2.  Contributions of Social Factors to Disparities in Prostate Cancer Risk Profiles among Black Men and Non-Hispanic White Men with Prostate Cancer in California.

Authors:  David J Press; Salma Shariff-Marco; Daphne Y Lichtensztajn; Diane Lauderdale; Adam B Murphy; Pushkar P Inamdar; Mindy C DeRouen; Ann S Hamilton; Juan Yang; Katherine Lin; Donald Hedeker; Christopher A Haiman; Iona Cheng; Scarlett Lin Gomez
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-30       Impact factor: 4.254

Review 3.  Landscape of Immunotherapy in Genitourinary Malignancies.

Authors:  Deepak Ravindranathan; Omar Alhalabi; Hind Rafei; Amishi Yogesh Shah; Mehmet Asim Bilen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Number of prostate-specific antigen (PSA) screening tests in the last five years reported by men in the United States in 2010, 2015, and 2018.

Authors:  Thomas B Richards; Shifan Dai; Simone C Gray; Ingrid J Hall; David A Siegel
Journal:  Urol Oncol       Date:  2022-02-27       Impact factor: 2.954

5.  Patterns of Prostate-Specific Antigen Test Use in the U.S., 2005-2015.

Authors:  Zahava Berkowitz; Jun Li; Thomas B Richards; Pamela M Marcus
Journal:  Am J Prev Med       Date:  2017-10-16       Impact factor: 5.043

6.  Geographic-Level Association of Contemporary Changes in Localized and Metastatic Prostate Cancer Incidence in the Era of Decreasing PSA Screening.

Authors:  Daniel X Yang; Danil V Makarov; Cary P Gross; James B Yu
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

7.  Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998-2017.

Authors:  Ashley Kieran Clift; Carol Ac Coupland; Julia Hippisley-Cox
Journal:  Br J Gen Pract       Date:  2021-01-28       Impact factor: 5.386

8.  Use of the prostate-specific antigen (PSA) test in the United States for men age ≥65, 1999-2015: Implications for practice interventions.

Authors:  Shahram Shahangian; Lin Fan; Krishna P Sharma; David A Siegel
Journal:  Cancer Rep (Hoboken)       Date:  2021-05-01

9.  The Association of Veterans' PSA Screening Rates With Changes in USPSTF Recommendations.

Authors:  Daniel J Becker; Temitope Rude; Dawn Walter; Chan Wang; Stacy Loeb; Huilin Li; Shannon Ciprut; Matthew Kelly; Steven B Zeliadt; Angela Fagerlin; Herbert Lepor; Scott Sherman; Joseph E Ravenell; Danil V Makarov
Journal:  J Natl Cancer Inst       Date:  2021-05-04       Impact factor: 13.506

10.  Use of the prostate-specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions.

Authors:  Shahram Shahangian; Krishna P Sharma; Lin Fan; David A Siegel
Journal:  Cancer Rep (Hoboken)       Date:  2021-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.